Exploring ‘Compassionate Use’

A two-day conference brought together representatives from government, pharmaceutical companies, patient groups, NGOs, and foundations, to discuss how to manage pre-approval access to medicines.

Published December 08, 2015

"Imagine that someone you love was a matter of days from succumbing to a fatal infection, but the drug of last resort-and your only hope - had not yet emerged from the trials and approvals needed to reach the marketplace," said Fred Guterl, BSEE, Executive Editor, Scientific American. How can our society, including patients, physicians, pharmaceutical companies, and government regulators, handle such cases in way that is compassionate, effective, and safe?

Such was the discussion on October 28 - 29 at the conference eBriefing, a multimedia conference report, as well as a Podcast, in mid-January.